ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 май 2023 13:01:01 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 май 2023 03:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 май 2023 13:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 мар 2023 13:01:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 мар 2023 03:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 мар 2023 13:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 янв 2023 03:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 ноя 2022 13:05:01 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 ноя 2022 13:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 окт 2022 03:50:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

30 авг 2022 13:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2022 Financial Results

11 авг 2022 13:01:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2022 Financial Results on Thursday, August 11, 2022

02 авг 2022 05:00:02 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of ZONISADE™ (Zonisamide Oral Suspension)

18 июл 2022 04:05:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Sale of Hospital Products

24 июн 2022 04:30:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2022 Financial Results

12 май 2022 13:02:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

03 май 2022 13:02:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer

11 апр 2022 13:01:00 Источник Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride Injection

11 апр 2022 04:30:00 Источник Nasdaq GlobeNewswire